• Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus Rating of "Buy" from Brokerages

    Source: Buzz FX / 10 Nov 2024 02:21:17   America/Chicago


    Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus Rating of "Buy" from Brokerages Written by MarketBeat November 10, 2024 Share Link copied to clipboard. Shares of Dyne Therapeutics, Inc. ( NASDAQ:DYN - Get Free Report ) have earned a
    Read more...
Share on,